KALA Kala Pharmaceuticals Inc

Price (delayed)

$2.24

Market cap

$41.64M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$98.14

Enterprise value

$39.88M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 9

Kala is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for diseases of the eye. Kala has applied its AMPPLIFY® mucus-penetrating particle (MPP) Drug Delivery ...

Highlights
KALA's debt has shrunk by 100% YoY
Kala Pharmaceuticals's equity has surged by 89% YoY and by 54% QoQ

Key stats

What are the main financial stats of KALA

KALA stock price

How has the Kala Pharmaceuticals stock price performed over time
Intraday
0%
1 week
-2.18%
1 month
-58.52%
1 year
-98.91%
YTD
-91.94%
QTD
-74.13%

Financial performance

How have Kala Pharmaceuticals's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$34.97M
Net income
-$19.65M
Gross margin
N/A
Net margin
N/A
Kala Pharmaceuticals's net income has increased by 45% YoY and by 27% QoQ
KALA's operating income is up by 20% QoQ and by 11% YoY

Price vs fundamentals

How does KALA's price correlate with its fundamentals

Growth

What is Kala Pharmaceuticals's growth rate over time

Valuation

What is Kala Pharmaceuticals stock price valuation
P/E
N/A
P/B
0.03
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has surged by 75% year-on-year and by 41% since the previous quarter
Kala Pharmaceuticals's equity has surged by 89% YoY and by 54% QoQ

Efficiency

How efficient is Kala Pharmaceuticals business performance
The return on equity has surged by 90% since the previous quarter
The ROIC has shrunk by 63% YoY but it rose by 9% QoQ
The company's return on assets fell by 46% YoY and by 4.5% QoQ

Dividends

What is KALA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for KALA.

Financial health

How did Kala Pharmaceuticals financials performed over time
KALA's current ratio has soared by 108% QoQ
The company's total liabilities has shrunk by 96% YoY and by 38% QoQ
KALA's debt is 100% lower than its equity
KALA's debt has shrunk by 100% YoY
The debt to equity has plunged by 100% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.